The Latest Cardiac and Vascular News
Medinol, a global Interventional Cardiology device company, announced that it obtained CE-mark for EluNIR™, its novel Drug Eluting Stent featuring a unique stent design with low metal footprint and a proprietary elastomeric coating, both designed to optimize clinical outcomes. EluNIR demonstrated outstanding outcomes in two randomized pivotal studies. In BIONICS, a more-comers […]
DENVER & EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–ACIST Medical Systems, Inc., a Bracco Group Company, today announced the global launch of its ACIST RXi® Mini™ System, the next generation system of its RXi Rapid Exchange FFR System. The RXi Mini System will debut at the 29th Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium […]
IRVINE, CALIFORNIA — (Marketwired) — Oct 25, 2017 — Novoheart (“Novoheart” or the “Company”) (TSX VENTURE: NVH), a global stem cell biotechnology company, is pleased to announce that it has opened a new US location in The Cove at UC Irvine, California. The Cove is home to UCI Applied Innovation – a public-private […]
SAN CLEMENTE, Calif., Oct. 26, 2017 /PRNewswire/ — Rox Medical Inc., a privately held medical device company pioneering an innovative interventional vascular therapy for uncontrolled hypertension, announced the publication of 12-month outcomes of the ROX CONTROL HTN study in the prestigious journal, Hypertension. CONTROL HTN is a multi-center randomized controlled trial that […]
HOUSTON–(BUSINESS WIRE)–October 26, 2017– CorInnova Inc., an emerging medical device company developing novel technology for the treatment of Heart Failure, announced today three milestone events: (1) the Company has received notice of allowance of a seminal patent to protect its intellectual property associated with the world’s first minimally invasively-delivered soft robotic […]
SAN ANTONIO, Oct. 26, 2017 /PRNewswire/ — CeloNova BioSciences, a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced that the U.S. Federal Drug Administration (FDA) approved expansion of CeloNova’s ongoing clinical trial of its proprietary COBRA PzF™ NanoCoated Coronary […]
A new study has found females and minorities have a greater risk of restenosis and subsequent MACE than “white” men after receiving everolimus-eluting stent implantation. The Study Setup A cohort study that pulled thousands of patients from both the PLATINUM Diversity and PROMUS Element Plus Post-Approval looked at groups of men, women […]
SAN FRANCISCO–(BUSINESS WIRE)–Bay Labs, a medical technology company at the forefront of applying artificial intelligence to cardiovascular imaging, today announced that Emeritus Professor of Medicine (Cardiology) at Emory University School of Medicine and the company’s Chief Medical Officer Randolph P. Martin, M.D. FACC, FASE, has been invited to be a […]
WASHINGTON, Oct. 25, 2017 /PRNewswire/ – Baylis Medical Company, a leading developer, manufacturer, and supplier of state-of-the-art interventional cardiology products, has announced that President and co-Founder Kris Shah has been named to the Advanced Medical Technology Association’s (AdvaMed) Accel Board of Directors. “I am honoured to be appointed to the AdvaMed Accel Board and look forward to […]
KFAR SABA, Israel, Oct. 24, 2017 /PRNewswire/ — Cathworks, a leader in the development of non-invasive Fractional Flow Reserve (FFR) measurements for guiding coronary interventions, announced today that the first patient has been enrolled in the FAST-FFR (FFRangio Accuracy vs. STandard FFR) clinical trial. This global pivotal trial is designed to assess the efficacy […]
